Cause of first death of a high school senior after vaccination is leukemia... "No causal link to vaccine" (Comprehensive)

[Asia Economy Reporter Seo So-jeong] The government announced that the first reported death of a teenager after receiving the COVID-19 vaccine was confirmed to have no causal relationship with the vaccination.

On the 18th, Kim Yuna, head of the Adverse Reaction Investigation Team at the COVID-19 Vaccination Response Task Force, said, "We offer our condolences to the deceased and their family," and added, "The Vaccination Damage Investigation Board determined that the case was caused by pancytopenia stemming from leukemia, which led to multiple intracerebral hemorrhages due to decreased platelets, and concluded there was no causal relationship with the vaccine."

Kim explained, "At the time of vaccination, leukemia was not recognized, and the vaccine was administered. Later, the leukemia diagnosis was made," and added, "On September 2, the Korean Society of Hematology announced that there is no causal relationship between the COVID-19 vaccine and leukemia."

Earlier, on the 30th of last month, the quarantine authorities received the first domestic report of a suspected death of a teenager following COVID-19 vaccination. The teenager, known to be a high school senior (Grade 3), received the Pfizer vaccine on August 13 and passed away 75 days later, on the 27th of last month.

Among 3,526 cases reviewed for vaccination damage, 487 cases were recognized as causally related to vaccination

The Vaccination Damage Investigation Board held its 38th meeting on the 12th to evaluate the causal relationship of reported adverse reactions following COVID-19 vaccination.

At this evaluation, 110 new cases were reviewed, and among them, causality with vaccination was recognized for 10 cases of anaphylaxis. One death and one severe illness case were assessed as having insufficient evidence.

So far, among 3,526 cases submitted for review involving death or severe illness after vaccination, 487 cases (2 deaths, 5 severe illnesses, and 480 anaphylaxis cases) have been recognized as causally related to vaccination. Fifty-five cases were evaluated as having insufficient evidence. Cases with insufficient evidence receive medical expense support up to 30 million KRW, and will be re-evaluated if further evidence is obtained.

Additionally, the Vaccination Damage Compensation Expert Committee held its 13th meeting on the 16th and reviewed 737 new compensation claims, deciding to compensate treatment costs for 273 cases treated for fever, headache, dizziness, allergic reactions, and other symptoms.

Out of a total of 82,065,212 vaccinations, as of midnight on the 15th, 374,456 cases were reported as suspected adverse reactions. Among these, 6,030 cases were submitted for compensation review by the committee up to the 13th meeting, and 2,679 cases (44.4%) were approved for compensation.

Meanwhile, the task force is also providing medical expense support of up to 30 million KRW per person through a medical expense support program for patients with severe or special interest adverse reactions after COVID-19 vaccination who were excluded from compensation due to insufficient causal evidence.

This content was produced with the assistance of AI translation services.